Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study
出版年份 2022 全文链接
标题
Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study
作者
关键词
-
出版物
Hepatology International
Volume 16, Issue 5, Pages 1170-1178
出版商
Springer Science and Business Media LLC
发表日期
2022-08-25
DOI
10.1007/s12072-022-10398-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A retrospective multicenter study
- (2022) Sabrina Welland et al. Liver Cancer
- Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea
- (2021) Myung Ji Goh et al. Liver Cancer
- Real-world effectiveness of lenvatinib monotherapy among unresectable hepatocellular carcinoma patients in the USA
- (2021) Amit G Singal et al. Future Oncology
- Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib
- (2021) M. Rimini et al. ESMO Open
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis
- (2020) Jaekyung Cheon et al. Liver Cancer
- Hypothyroidism is a Predictive Factor for Better Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Undergoing Lenvatinib Therapy
- (2020) Masako Shomura et al. Cancers
- Australian recommendations for the management of hepatocellular carcinoma: a consensus statement
- (2020) John S Lubel et al. MEDICAL JOURNAL OF AUSTRALIA
- Association between overall survival and adverse events with lenvatinib treatment in patients with hepatocellular carcinoma (REFLECT).
- (2019) Max W. Sung et al. JOURNAL OF CLINICAL ONCOLOGY
- The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting
- (2019) Shuntaro Obi et al. Hepatology International
- Lenvatinib for the treatment of HCC: A single institute experience.
- (2019) San-Chi Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis
- (2018) Atsushi Hiraoka et al. Cancer Medicine
- Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study
- (2016) Adam Doyle et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Epidemiology of Hepatocellular Carcinoma
- (2013) Sahil Mittal et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma
- (2013) Ju-Yeon Cho et al. LIVER INTERNATIONAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started